Back
ESC Professional Premium Access

Maximum dose sacubitril/valsartan in heart failure with reduced ejection fraction: does atrial fibrillation compromise the benefits?

Session: Heart failure pharmacotherapy - Sacubitril/valsartan
Topic: Pharmacotherapy
Speaker: Doctor G. Oliveira Campos (Coimbra, PT)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Gustavo Manuel Oliveira Campos

University Hospitals of Coimbra, Coimbra (Portugal)
0 follower

7 more presentations in this session

Haemodynamic forces as predictors of cardiac remodelling and outcome in heart failure with reduced ejection fraction treated with sacubitril/valsartan

Speaker: Assistant Professor A. Giannoni (Pisa, IT)

Access
Abstract
Slides
Like
Thumbnail

Efficacy and safety of sacubitril valsartan in heart failure compared to renin angiotensin aldosterone system inhibitors: a systematic review and meta analysis of randomised controlled trials

Speaker: Professor A. Bielecka-Dabrowa (Lodz, PL)

Access
Abstract
Slides
Like
Thumbnail

Effects of sacubitril valsartan on renal function in adults with heart failure: a systematic review and meta analysis of randomised controlled trials

Speaker: Professor A. Hernandez (Storrs, US)

Access
Abstract
Slides
Like
Thumbnail

Heart failure with improved ejection fraction (HFimpEF) in patients treated with sacubitril/valsartan (SV)

Speaker: Assistant Professor K. Lee (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

Comparative effectiveness of sacubitril/valsartan versus angiotensin converting enzyme inhibitors/angiotensin receptor blockers in de novo heart failure patients

Speaker: Doctor H. Schwende (Basel, CH)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Heart failure pharmacotherapy - Sacubitril/valsartan

Speakers: Doctor G. Oliveira Campos, Assistant Professor A. Giannoni, Professor A. Bielecka-Dabrowa, Professor A. Hernandez, Assistant Professor K. Lee...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources